Board of Directors

James Bland is the Executive Director of CRIX International, and has more than 20 years of work experience in both the government and private industry, including technology development, international finance, marketing and strategic analysis. He has been a key leader in the vision, creation, and progression of CRIX International. Prior to his current work, James has held several prominent positions in different companies including Ergonomixx, Datalux, Corstone Capital, and Science Applications International Corporation, where his work included development of electronic health record (EHR) systems, as well as web-based information exchange platforms for various markets. James' work experience encompasses countries in the Middle East, Eastern and Western Europe, and Asia. James earned an MBA from Harvard Business School after graduating cum laude from Wake Forest University with a BA in Politics and French.

Deb Bremer is Vice President of Development & Medical Informatics for Pfizer, Inc. She leads a global team of professionals who provide informatics strategy and services spanning pre-clinical safety testing through all phases of drug development, regulatory submissions, external healthcare, medical affairs, and commercial therapeutic area support. Prior to joining Pfizer, Deb held positions of increasing responsibility in General Dynamics' Data Systems Division and Computer Sciences Corporation's Technology Management Group. She holds a BS in Computer Science from the State University of New York, and an MBA with a concentration in Management and Organization from the University of New Haven, Connecticut.

Sue Dubman is Senior Director of System and Data Architecture at Genzyme, serving in the role of chief data officer, and Chairperson of CRIX International's North American Advisory Council (NAAC). Sue has more than 20 years of experience in information technology with a specialization in life sciences and healthcare. Prior to Genzyme, Sue was Vice President of Information Technology at Theravance. Before Theravance, Sue was Director of Biomedical Informatics at the NCI, where she helped lead several major programs that are widely recognized for their potential to change the way research is done, drugs are developed, and patients and providers interact with the health care enterprise. These include the Cancer Biomedical Informatics Grid or caBIG™; the joint FDA/NCI Inter-Agency Oncology Task Force initiative which become the first rendition of CRIX and included both the initial Janus (CDISC SDTM data repository) and FIREBiRD pilots; a CDISC-HL7-FDA-NCI collaboration called BRIDG; and a translational research platform (caIntegrator) to enable genomic medicine. Sue completed work towards her PhD at Brown University in population sciences and received her MA and BA from the University of Missouri.

Diana L. McKenzie is Vice President, Information Systems Infrastructure, for Amgen, Inc. Diana has responsibility for leading the global development and delivery of Amgen's Information Systems Infrastructure Services. In her role, she leads a team that plans, develops, deploys, and operates a variety of IT services. Prior to joining Amgen, Diana served for 17 years in a variety of Information Systems Leadership roles at Eli Lilly. She has chaired the PhRMA Trade Association's Information Management Leadership Committee (IMPACC), served on the PDUFA III IT FDA Advisory Committee as well as the Department of Health and Human Services Biosurveillance IT Working Group, has led the PhRMA IMPACC e-Health Futures Subcommittee, and recently joined Purdue University's School of Technology, Executive Advisory Board. She received her Bachelor of Science degree from Purdue University's School of Computer Technology in 1986 and was recognized by the university as a Distinguished Alumni in the spring of 2004.